IB

Ilias Basha Shaik

Director Director DIN 09102205
DIN 09102205 First appointment Mar 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2021
Shareholding value Locked Premium profile

About Ilias Basha Shaik

Ilias Basha Shaik has 5 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 09102205
Primary Designation Director
First Appointment 11 Mar 2021
Oldest Company Age 5 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Zyta Pharmaceuticals Private Limited U74999KA2021PTC145191
Director 11 Mar 2021 2021 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zyta Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ilias Basha Shaik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ilias Basha Shaik

Ilias Basha Shaik has 5 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Ilias Basha Shaik is associated with 0 companies as Director.

Ilias Basha Shaik has expertise in General Business.

Ilias Basha Shaik has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available